Cargando…
Antiviral and immunomodulatory effects of polyphenols on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies
Background: There is a lack of specific antiviral therapy against dengue virus (DENV) in current use. Therefore, a great proportion of dengue cases progress to severe clinical forms due to a complex interplay between virus and host immune response. It has been hypothesized that heterotypic non-neutr...
Autores principales: | Jasso-Miranda, Carolina, Herrera-Camacho, Irma, Flores-Mendoza, Lilian Karem, Dominguez, Fabiola, Vallejo-Ruiz, Veronica, Sanchez-Burgos, Gilma Guadalupe, Pando-Robles, Victoria, Santos-Lopez, Gerardo, Reyes-Leyva, Julio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611719/ https://www.ncbi.nlm.nih.gov/pubmed/31303775 http://dx.doi.org/10.2147/IDR.S210890 |
Ejemplares similares
-
Low Activation of CD8(+) T Cells in response to Viral Peptides in Mexican Patients with Severe Dengue
por: Estrada-Jiménez, Tania, et al.
Publicado: (2022) -
Taraxacum officinale and Urtica dioica extracts inhibit dengue virus serotype 2 replication in vitro
por: Flores-Ocelotl, María R., et al.
Publicado: (2018) -
Interferon lambda inhibits dengue virus replication in epithelial cells
por: Palma-Ocampo, Helen K., et al.
Publicado: (2015) -
IL-10 and socs3 Are Predictive Biomarkers of Dengue Hemorrhagic Fever
por: Flores-Mendoza, Lilian Karem, et al.
Publicado: (2017) -
Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2
por: de la Guardia, Carolina, et al.
Publicado: (2018)